
A great sign of trust
Chris Lauber has been elected to the Executive Committee of the International Committee on Taxonomy of Viruses

TWINCORE was founded in 2008 by the Helmholtz Centre for Infection Research and the Hannover Medical School. We combine the expertise of medical professionals and scientists from a wide range of disciplines to find answers to the pressing questions in infection research. Our focus: translational research – the bridge between basic science and clinical application.

Chris Lauber has been elected to the Executive Committee of the International Committee on Taxonomy of Viruses

Tolerogenic dendritic cells offer a niche for human cytomegalovirus

Researchers investigate the impact on the immune system.
We conduct translational infection research to improve the prevention, diagnosis and treatment of infectious diseases in humans. We focus on three areas that characterize our research work. Find out here how we proceed and what results we achieve.
Under the leadership of our best scientists, various labs are working on different projects within our research topics.
Lietzau A, Kolde H, Tapken I, Haal K, Kim S, Klein S, Souleiman R, Freyer E, Kraft A, Schütte S, Tergast T, Maasoumy B, Wedemeyer H, Niehaus I, Zurek G, Shin E, Cornberg M, Niehaus C
Souleiman R, Chou Y, Yang T, Freyer E, Carpentier A, Dey S, Niehaus C, Wintersteller H, Falk C, Maasoumy B, Ravens S, Wedemeyer H, Kraft A, Heinrich B, Cornberg M
Rahmel-Stein K, Becker J, Lange B, Krajewski L, Eiz-Vesper B, Kalinke U
The project investigates the immune response of the central nervous system in viral infections, in particular the role of type I IFN, microglia and monocytes in the development of encephalitis and their influence on seizures and hippocampal damage.
The project will investigate the immunological and genetic causes of vaccination failure in 5% of HBV-vaccinated individuals in order to develop new strategies to improve vaccination protection.
The project investigates the factors that determine the species barrier mechanism of HCV and make it impossible to study the infection in animal models. The aim is to use genetic screening systems to develop in vivo models for vaccine research.
Thanks to high-throughput sequencing, genome sequences of hundreds of bacterial strains can be analyzed efficiently, revealing differences of up to 60 % in gene content, as in E. coli. With the help of machine learning, we want to better predict the functions of accessory genes and decipher their contribution to survival in specialized niches.
There are currently no events.

